REGULATORY

• DPP Submits Request to MOF for Scrapping Off-Year Revisions
  December 5, 2024

• (Update) Average NHI-Market Price Gap Narrows to 5.2% to Hit Record Low
  December 4, 2024

• LDP Sees Growing Chorus of Opposition to Off-Year Revisions
  December 4, 2024

• Japan Expected to Include Shingles Vaccines in NIP from FY2025
  December 4, 2024

• Opposition DPP Leader Pledges to Go Full Throttle on Ending Off-Year Revisions
  December 3, 2024

• Qalsody, Zepbound, Zeposia Inch Closer to Japan Approval with Panel OK
  December 3, 2024

• LDP Pharma Study Group Renews Call for Ditching Off-Year Revisions
  December 3, 2024

• Japan Cabinet OKs Extra Budget, 44 Billion Yen for Pharma Measures
  December 2, 2024

• Pharma Industry Makes Plea to Komeito to Scrap Off-Year Revisions
  December 2, 2024

• Japan Partially Eases Rule for Use of Abortion Pill Mefeego
  December 2, 2024

• MOF Panel Wants Prioritized Budgeting for Drug Costs: Subcommittee Acting Chair
  December 2, 2024

• MOF Panel Urges Annual Price Revisions on All Drugs in 2025 Budget Proposal
  November 29, 2024

• Japan to Require Drug Makers to Set Up Legal Post of “Stable Supply Manager”
  November 29, 2024

• Japan Set to Put Up 100 Billion Yen to Support Pharma under Economic Package
  November 29, 2024

• Orphan Tag Given to Renalys’ IgA Nephropathy Therapy and 13 More Drugs
  November 29, 2024

• Scrap Off-Year Price Revisions, Smaller Japan Firms Face Uphill Battle: DPP Exec
  November 28, 2024

• DPP Confirms Plan to Urge 4 Ministers to Scrap Off-Year Price Revisions
  November 28, 2024

• Panel OKs 1-Year Extension of HPV Catch-Up Vaccinations, with Strings Attached
  November 28, 2024

• Sakigake Tag Granted for Iclepertin, Brogidirsen
  November 28, 2024

• MHLW Seeks Comments on Rx-to-OTC Switch of Tadalafil, 2 Other APIs
  November 27, 2024

ページ

• « 先頭
• ‹ Prev
• …
• 33
• 34
• 35
• 36
• 37
• 38
• 39
• 40
• 41
• …
• Next ›
• 最終 »